Épisodes

  • Ep. 49 - Is There Such A Thing As A High Functioning Stoner?

    Ep. 49 - Is There Such A Thing As A High Functioning Stoner?
    Feb 5 2025
    Stoner. Pothead. Loser. Couch potato. These are just a few of the choice names for individuals who choose to use a plant to self-medicate or relax. The stereotypes related to the cannabis enthusiast have been crafted over decades of lies and deceit, and in the public eye, cannabis is promoted as a harmful gateway drug only used by the lowest elements of our society. That stereotype is changing fast, as numerous high-profile individuals, like Elon Musk and Robert F. Kennedy Jr., have come out in support of cannabis legalization and appropriate use. To further the conversation, new evidence is indicating that yes, indeed, there are numerous benefits to using cannabis for health and well-being. And within our own culture, we see it every day as high-functioning stoners operate multi-million dollar businesses, participate in physical activity, and perform their daily adult responsibilities without incident. In this episode of Cannabis Nurse Truths, we consider the high-functioning stoner, a mythical creature that is gaining in population as the US continues to move toward cannabis legalization. EPISODE RESOURCES Anderson, D.M., Fe, H.T., Liang, Y., & Sabia, J.J. (2024). Recreational marijuana laws and teen marijuana use, 1993-2021. JAMA Psychiatry, 81(8), 840–842. https://doi.org/10.1001/jamapsychiatry.2024.0698 Bradford, A.C., Lozano-Rojas, F., Shone, H.B., Bradford, W.D., & Abraham, A.J. (2024). Cannabis laws and utilization of medications for the treatment of mental health disorders. JAMA Network Open, 7(9), e2432021. https://doi.org/10.1001/jamanetworkopen.2024.32021 Brenan, M. (2022, August 5). More in U.S. Say Alcohol Adversely Affects Drinkers, Society. Gallup. https://news.gallup.com/poll/395867/say-alcohol-adversely-affects-drinkers-society.aspx Brown, D. (2025, January 14). Canada's Medical Cannabis Market Remains Steady, Exports Continue to Increase. StratCann. https://stratcann.com/news/canada-medical-cannabis-market-exports-increase/ Caulkins, J. P. (2024). Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction, 119(9), 1648–1652. https://doi.org/10.1111/add.16519 Cavalli, J. M., Cuttler, C., & Cservenka, A. (2025). A naturalistic examination of the acute effects of high-potency cannabis on emotion regulation among young adults: A Pilot study. Human Psychopharmacology: Clinical and Experimental, 40(1), e2915. https://doi.org/10.1002/hup.2915 Centers for Disease Control and Prevention. (2024, August 6). CDC Data Show Improvements in Youth Mental Health but Need for Safer and More Supportive Schools. https://www.cdc.gov/media/releases/2024/p0806-youth-mental-health.html Choo, E.K., Trent, S.A., Nishijima, D.K., Eichelberger, A., Kazmierczak, S., Ye, Y., Brasel, K.J., Audett, A., & Cherpitel, C.J. (2024). Risk of motor vehicle collision associated with cannabis and alcohol use among patients presenting for emergency care. Accident Analysis & Prevention, 198, 107459. https://doi.org/10.1016/j.aap.2024.107459 Coley, R.L., Carey, N., Kruzik, C., Hawkins, S.S., & Baum, C.F. (2024). Recreational cannabis legalization, retail sales, and adolescent substance use through 2021. JAMA Pediatrics, 178(6), 622–625. https://doi.org/10.1001/jamapediatrics.2024.0555 Colorado Department of Public Health & Environment. (2022, June 15). CDPHE releases latest Healthy Kids Colorado Survey data. https://cdphe.colorado.gov/press-release/cdphe-releases-latest-healthy-kids-colorado-survey-data-0 De La Torre, I.D., Hébert, E.T., Kezbers, K.M., Walters, D., Pope, Z.C., Mao, B., Benson, L., Shi, D., Stanley, N., & Businelle, M.S. (2025). Associations between cannabis use and same-day health and substance use behaviors. Addictive Behaviors, 163, 108239. https://doi.org/10.1016/j.addbeh.2024.108239 English, F., & Whitehill, J.M. (2023). Risk factors for adolescent cannabis use in a state with legal recreational cannabis: The role of parents, siblings, and friends. Clinical Therapeutics, 45(6), 589–598. https://doi.org/10.1016/j.clinthera.2023.04.002 Grimm, B. (2017, April 20). 50 Most Successful Marijuana Enthusiasts You Should Know. Rolling Stone. https://www.rollingstone.com/culture/culture-lists/50-most-successful-marijuana-enthusiasts-you-should-know-114790/zayn-malik-3-112209/ Karmakar, B., Mukherjee, G., & Kar, W. (2024). Using penalized synthetic controls on truncated data: A case study on effect of marijuana legalization on direct payments to physicians by opioid manufacturers. Journal of the American Statistical Association, 1–16. https://doi.org/10.1080/01621459.2024.2406583 Marijuana Policy Project. (2025, January 9). New Data Shows Adult-Use Cannabis Legalization Corresponds with Drops in Teen Use. https://www.mpp.org/news/press/new-data-shows-adult-use-cannabis-legalization-corresponds-with-drops-in-teen-use/ McCarthy, J. (2024, August 10). Fully Half of Americans Have Tried Marijuana. Gallup. https://news.gallup.com/poll/509399/...
    Voir plus Voir moins
    1 h et 19 min
  • Ep. 48 - The Entourage Effect is Still a Theory

    Ep. 48 - The Entourage Effect is Still a Theory
    Jan 29 2025
    In 1998, a group of researchers proposed a hypothesis known as the Entourage Effect, in which a multitude of the compounds found in cannabis can synergistically work together based on the fact that these effects were also seen in the synergism properties associated with our own endocannabinoids. However, after 26 years, this hypothesis has never been supported clinically, meaning that while we have a lot of proposals and a lot of research suggesting interactions, we've never actually applied it to a patient population in a real-life setting. In this episode of Cannabis Nurse Truths, we examine this hypothesis known as the Entourage Effect, because while there is a lot of research suggesting this phenomenon is occurring, meaning that something is happening - we just don't know what it is - critics state that there is not enough evidence to support this in science. Their claim is that it is really just a marketing tool to help promote cannabis products. So which is it - an actual phenomenon that explains why cannabis compounds work together to heal the body, or is it just a gimmick to sell more weed? Bottom line; cannabis contains over 500 compounds that all have beneficial physiological effects, so does it really matter which is true? EPISODE RESOURCES Al-Khazaleh, A.K., Zhou, X., Bhuyan, D.J., Münch, G.W., Al-Dalabeeh, E.A., Jaye, K., & Chang, D. (2024). The neurotherapeutic arsenal in Cannabis sativa: Insights into anti-neuroinflammatory and neuroprotective activity and potential entourage effects. Molecules, 29(2), Article 2. https://doi.org/10.3390/molecules29020410 Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998). An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology, 353(1), 23–31. https://doi.org/10.1016/S0014-2999(98)00392-6 Blasco-Benito, S., Seijo-Vila, M., Caro-Villalobos, M., Tundidor, I., Andradas, C., García-Taboada, E., Wade, J., Smith, S., Guzmán, M., Pérez-Gómez, E., Gordon, M., & Sánchez, C. (2018). Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochemical Pharmacology, 157, 285–293. https://doi.org/10.1016/j.bcp.2018.06.025 Boggs, D.L., Nguyen, J.D., Morgenson, D., Taffe, M.A., & Ranganathan, M. (2018). Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinol. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 43(1), 142–154. https://doi.org/10.1038/npp.2017.209 Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023). Decoding the postulated entourage effect of medicinal cannabis: What it is and what it isn’t. Biomedicines, 11(8), 2323. https://doi.org/10.3390/biomedicines11082323 Cogan, P.S. (2020). The “entourage effect” or “hodge-podge hashish”: The questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Review of Clinical Pharmacology, 13(8), 835–845. https://doi.org/10.1080/17512433.2020.1721281 Cunha, J.M., Carlini, E.A., Pereira, A.E., Ramos, O.L., Pimentel, C., Gagliardi, R., Sanvito, W.L., Lander, N., & Mechoulam, R. (1980). Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 21(3), 175–185. https://doi.org/10.1159/000137430 Fowler, C.J. (2003). Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents non-psychoactive cannabinoids, ‘entourage’ compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid psychotropic effects. Brain Research Reviews, 18. https://pubmed.ncbi.nlm.nih.gov/12505646/ Gallily, R., Yekhtin, Z., & Hanuš, L.O. (2015). Overcoming the bell‐shaped dose‐response of cannabidiol by using cannabis extract enriched in cannabidiol. Pharmacology & Pharmacy, 6(02), 75–85. https://doi.org/10.4236/pp.2015.62010 Namdar, D., Anis, O., Poulin, P., & Koltai, H. (2020). Chronological review and rational and future prospects of cannabis-based drug development. Molecules, 25(20), Article 20. https://doi.org/10.3390/molecules25204821 Pamplona, F.A., da Silva, L.R., & Coan, A.C. (2018). Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: Observational data meta-analysis. Frontiers in Neurology, 9, 759. https://doi.org/10.3389/fneur.2018.00759 Russo, E.B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects: Phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x Russo, E.B. (2016). Beyond cannabis: Plants and the endocannabinoid system. Trends in Pharmacological Sciences, 37(7), 594–605. https://doi.org/...
    Voir plus Voir moins
    1 h et 19 min
  • Ep. 47 - Cannabis in 2024: A Year In Review

    Ep. 47 - Cannabis in 2024: A Year In Review
    Jan 22 2025
    Welcome back to our Cannabis Nurse Truths podcast! Lee and I took some much-needed time off for the holidaze but we are back to share more truths about cannabis as we move into a new year. 2024 was a crazy year for the cannabis industry, and in the United States, we anticipate more changes as federal, state, and even global perceptions of cannabis shift dramatically. In this episode, we reflect on some of the major events that happened in the cannabis industry that saw both successes and failures for everyone involved in cannabis - both businesses and users. But from my perspective as a cannabis nurse, I recognize the underlying trend across the US - cannabis is being used by so many individuals that it can no longer be denied - cannabis is medicine. Welcome to Cannabis Nurse Truths in 2025! EPISODE RESOURCES Bailey, J.A., Tiberio, S.S., Kerr, D.C.R., Epstein, M., Henry, K.L., & Capaldi, D.M. (2023). Effects of cannabis legalization on adolescent cannabis use across 3 studies. American Journal of Preventive Medicine, 64(3), 361–367. https://doi.org/10.1016/j.amepre.2022.09.019 Ballard, J. (2024, July 17). Marijuana Leads Alcohol For Daily Usage. Alcohol Is Well Ahead For Monthly Usage. YouGov. https://today.yougov.com/health/articles/50106-marijuana-leads-alcohol-daily-usage-alcohol-ahead-monthly-usage Bradford, A.C., Lozano-Rojas, F., Shone, H.B., Bradford, W.D., & Abraham, A.J. (2024). Cannabis laws and utilization of medications for the treatment of mental health disorders. JAMA Network Open, 7(9), e2432021. https://doi.org/10.1001/jamanetworkopen.2024.32021 Business Wire. (2025, January 16). The Two Largest Cannabis Industry Groups Combine Policy Advocacy Efforts To Form Singular, Leading Authority Representing Industry In Washington. https://www.businesswire.com/news/home/20250116788639/en/The-Two-Largest-Cannabis-Industry-Groups-Combine-Policy-Advocacy-Efforts-to-Form-Singular-Leading-Authority-Representing-Industry-in-Washington Carrión, R.E., Auther, A.M., McLaughlin, D., Adelsheim, S., Burton, C.Z., Carter, C.S., Niendam, T., Ragland, J.D., Sale, T.G., Taylor, S.F., Tso, I.F., McFarlane, W.R., & Cornblatt, B.A. (2023). Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns. Psychiatry Research, 328, 115420. https://doi.org/10.1016/j.psychres.2023.115420 Caulkins, J. P. (2024). Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction, 119(9), 1648–1652. https://doi.org/10.1111/add.16519 Cavendish, V. (2025, January 9). New Data Shows Adult-Use Cannabis Legalization Corresponds with Drops in Teen Use. Marijuana Policy Project. https://www.mpp.org/news/press/new-data-shows-adult-use-cannabis-legalization-corresponds-with-drops-in-teen-use/ Centers for Disease Control and Prevention. (n.d.). Youth Risk Behavior Survey: Data Summary & Trends Report 2013-2023. U.S. Department of Health and Human Services. https://www.cdc.gov/yrbs/dstr/pdf/YRBS-2023-Data-Summary-Trend-Report.pdf Colorado Department of Public Health & Environment. (2022, June 15). CDPHE Releases Latest Healthy Kids Colorado Survey Data. https://cdphe.colorado.gov/press-release/cdphe-releases-latest-healthy-kids-colorado-survey-data-0 Darakjian, L., Glassman, H., Lo, C.Y., & Russo, F. (2024). Exploring the interaction between cannabis, hearing, and music. OSF. https://doi.org/10.31234/osf.io/pmuhx Evoy, R., & Victoroff, T. (2024). Prevalence of cannabis use among US workers in 15 states, 2016–2020. American Journal of Public Health, 114(S8), S645–S653. https://doi.org/10.2105/AJPH.2024.307788 Halman, A., Chenhall, R., & Perkins, D. (2024). Changes in pain and mental health symptoms associated with prescribed medicinal cannabis use: A one-year longitudinal study. Journal of Pain & Palliative Care Pharmacotherapy, 1–13. https://doi.org/10.1080/15360288.2024.2414898 Herrington, A.J. (2025, January 13). DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week. Forbes. https://www.forbes.com/sites/ajherrington/2025/01/13/dea-judge-cancels-marijuana-rescheduling-hearing-set-for-next-week/ Jaeger, K. (2025, January 8). New York Marijuana Consumption Lounges Could Sell Food And Drinks While Hosting Live Concerts Under New Bill. Marijuana Moment. https://www.marijuanamoment.net/new-york-marijuana-consumption-lounges-could-sell-food-and-drinks-while-hosting-live-concerts-under-new-bill/ Karmakar, B., Mukherjee, G., & Kar, W. (2024). Using penalized synthetic controls on truncated data: A case study on effect of marijuana legalization on direct payments to physicians by opioid manufacturers. Journal of the American Statistical Association, 0(0), 1–16. https://doi.org/10.1080/01621459.2024.2406583 Leatherdale, S.T., Amores, A., Bélanger, R.E., Battista, K., Patte, K.A., & Jiang, Y. (2023). Youth perception of difficulty accessing cannabis following cannabis ...
    Voir plus Voir moins
    1 h et 19 min
  • Ep. 46 - FAAH-Out: The Curious Case of Joanne Cameron

    Ep. 46 - FAAH-Out: The Curious Case of Joanne Cameron
    Dec 4 2024
    Several years ago, a medical case appeared that took the scientific and medical community by storm. A patient appeared for surgery who reported never feeling anxiety, depression, or pain, despite numerous injuries and surgeries for which she required treatment. As scientists analyzed her genetic profile, they discovered something amazing - Joanne Cameron lacked the genetic code that was responsible for transmitting pain and creating anxiety and depression. In this episode of Cannabis Nurse Truths, we examine the curious case of Joanne Cameron that has led to some very surprising research that targets this important physiological phenomenon, and drug companies are furiously developing drugs to capitalize on this incredible potential to decrease pain, anxiety, depression, and treat a number of psychological and physical disorders. One of the most incredible findings linked to this case: cannabinoids, like CBD, also enhance the natural physiological activities of the body linked to the FAAH-OUT gene, where inflammation is halted (reducing pain), while also reducing or eliminating anxiety and depression. EPISODE RESOURCES Ahn, K., Johnson, D. S., & Cravatt, B. F. (2009). Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opinion on Drug Discovery, 4(7), 763–784. https://pmc.ncbi.nlm.nih.gov/articles/PMC2882713/pdf/nihms-116402.pdf Bartel, S. J., Sherry, S. B., & Stewart, S. H. (2020). Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic. Substance Abuse, 41(4), 409–412. https://pubmed.ncbi.nlm.nih.gov/33044893/ Bisogno, T., & Maccarrone, M. (2013). Latest advances in the discovery of fatty acid amide hydrolase inhibitors. Expert Opinion on Drug Discovery. https://www.researchgate.net/publication/236044861_Latest_advances_in_the_discovery_of_fatty_acid_amide_hydrolase_inhibitors Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., Houle, S., Kish, S. J., & Tong, J. (2016). Fatty acid amide hydrolase binding in brain of cannabis users: Imaging with the novel radiotracer [11C]CURB. Biological Psychiatry, 80(9), 691–701. https://pubmed.ncbi.nlm.nih.gov/27345297/ Bornscheuer, L., Lundin, A., Forsell, Y., Lavebratt, C., & Melas, P. A. (2023). Functional variation in the FAAH gene is directly associated with subjective well-being and indirectly associated with problematic alcohol use. Genes, 14(9), 1826. https://pubmed.ncbi.nlm.nih.gov/37761966/ Cravatt, B.F., & Lichtman, A.H. (2003). Fatty acid amide hydrolase: An emerging therapeutic target in the endocannabinoid system. Current Opinion in Chemical Biology, 7(4), 469–475. https://pubmed.ncbi.nlm.nih.gov/12941421/ Di Marzo, V., & Petrosino, S. (2007). Endocannabinoids and the regulation of their levels in health and disease. Current Opinion in Lipidology, 18(2), 129–140. https://pubmed.ncbi.nlm.nih.gov/17353660/ D’Souza, D. C., Cortes-Briones, J., Creatura, G., Bluez, G., Thurnauer, H., Deaso, E., Bielen, K., Surti, T., Radhakrishnan, R., Gupta, A., Gupta, S., Cahill, J., Sherif, M. A., Makriyannis, A., Morgan, P. T., Ranganathan, M., & Skosnik, P. D. (2019). Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: A double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. Lancet Psychiatry, 6(1), 35–45. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30427-9/abstract Girella, A., Di Bartolomeo, M., Dainese, E., Buzzelli, V., Trezza, V., & D’Addario, C. (2024). Fatty acid amide hydrolase and cannabinoid receptor type 1 genes regulation is modulated by social isolation in rats. Neurochemical Research, 49(5),1278-1290. http://www.ncbi.nlm.nih.gov/pubmed/38368587 Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004). Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology, 29(11), 2108–2114. https://www.nature.com/articles/1300558 Habib, A. M., Okorokov, A. L., Hill, M. N., Bras, J. T., Lee, M.-C., Li, S., Gossage, S. J., van Drimmelen, M., Morena, M.,Houlden, H., Ramirez, J. D., Bennett, D. L. H., Srivastava, D., & Cox, J. J. (2019). Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. British Journal of Anaesthesia, 123(2), e249–e253. https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6676009&blobtype=pdf Haseltine, W.A., (2023). No pain, FAAH-OUT. Forbes. https://www.forbes.com/sites/williamhaseltine/2023/06/19/no-pain-faah-out/ Huggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012). An efficient randomised, placebo-controlled ...
    Voir plus Voir moins
    1 h
  • Ep. 45 - Cruel Consequences: Portraits of Misguided Law - With Special Guest Tamara Lyn Netzel

    Ep. 45 - Cruel Consequences: Portraits of Misguided Law - With Special Guest Tamara Lyn Netzel
    Nov 27 2024

    In the schizophrenic United States of Cannabis, Americans have been denied fundamental Constitutional Rights because of their choice to use a plant. Long after court requirements are satisfied from a marijuana charge, many Americans are denied basic rights like employment, voting, housing, property, child custody, and college loans that keep them from Life, Liberty, and the Pursuit of Happiness. As the laws and regulations regarding cannabis undergo extreme transformations, Americans are still subjected to discrimination, but now, there could be a light on the horizon.

    In this episode of Cannabis Nurse Truths, we are excited to host our first poTcast guest, Tamara Lyn Netzel, a nationally-recognized cannabis advocate and author, who has just published her second book, Humans of Cannabis in a Renaissance of Hope, highlighting the struggles and successes of normal everyday Americans who have decided that cannabis is their drug - or medicine - of choice. Tamara is the founder of the non-profit 501c3 Cruel Consequences: Portraits of Misguided Law after becoming a medical cannabis advocate for treatment of her multiple sclerosis symptoms and in this episode of CNT, we discuss her journey to cannabis as medicine and her passion for cannabis advocacy.

    EPIDSODE RESOURCES

    Cruel Consequences: Portraits of Misguided Law https://cruelconsequences.org/

    Amazon: Humans of Cannabis in a Renaissance of Hope https://www.amazon.com/Humans-Cannabis-Tamara-Lyn-Netzel/dp/B0DHJH9HJV?sr=8-1

    Portraits of Misguided Law: The Human Cost of Marijuana Prohibition https://checkout.square.site/buy/RLKFXWPJQ5N4K6HDMBMBEVSL

    Voir plus Voir moins
    1 h et 10 min
  • Ep. 44 - Buzz Kill: The 1937 Marijuana Tax Act

    Ep. 44 - Buzz Kill: The 1937 Marijuana Tax Act
    Nov 20 2024

    In order to understand how we ended up in the schizophrenic United States of Cannabis, we have to travel back in time to when cannabis was part of the American experience. For nearly 150 years after the first colony was established in Jamestown, Virginia, cannabis was utilized for spiritual rituals, rope, fibers, textiles, bird seed, oils and medicine, both for humans and pets. Until one day, a bunch of men in business suits decided that they needed a lot of money to start a war on drugs.

    In this episode of Cannabis Nurse Truths, we take a look at the very mixed-up and unfair hijinks used by the Federal government agencies that would later also benefit from its prohibition. It is all too apparent that our federal government is seriously flawed and even worse, those government entities who created this national psychosis are still benefiting from the effects of prohibition over 80 years later.

    EPISODE RESOURCES

    Adams, E. S. (2024). Just don’t do it: Why cannabis regulations are the reason cannabis businesses are failing. Nevada Law Journal, 24(349). https://scholars.law.unlv.edu/cgi/viewcontent.cgi?article=1935&context=nlj0

    Galliher, J. F., & Walker, A. (1977). The puzzle of the social origins of the Marihuana Tax Act of 1937. Social Problems, 24(3), 367–376. https://doi.org/10.2307/800089

    Griffith, R. C. (2021). A breath of fresh air: A Constitutional amendment legalizing marijuana through an Article V Convention of the States. University of Massachusetts Law Review, 16(200), Article 2. https://scholarship.law.umassd.edu/umlr/vol16/iss2/2

    LaGuardia, F. (1944). The Laguardia Committee Report New York, USA (1944). https://rodneybarnett.net/PDF/Laguardia%20Report%201944.pdf

    Last Prisoner Project. (n.d.). Exactly how many people are locked up for weed? https://www.lastprisonerproject.org/cannabis-prisoner-scale

    National Conference of State Legislatures. (n.d.). State Medical Cannabis Laws. https://www.ncsl.org/health/state-medical-cannabis-laws?__cf_chl_tk=jj5C1HNOjfrPgfuAOfFuEtsRvbrl0ufw5tdRo54kBBk-1730819983-1.0.1.1-3WmtBp1aGo4X66bWfielCviKdPcDqEI.k1hG1LmOiH4

    National Institute on Alcohol Abuse and Alcoholism. (2024). Alcohol Use in the United States: Age Groups and Demographic Characteristics. National Institutes of Health. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-use-united-states-age-groups-and-demographic-characteristics

    Musto, D. F. (1972). The 1937 Marijuana Tax Act. Archives of General Psychiatry, 26, 101-108. https://static1.squarespace.com/static/54b9fbd9e4b0b6737df63e5d/t/627af393d870030771a32aa1/1652224915619/The+1937+Marijuana+Tax+Stamp+Act-Musto-1972.pdf

    Patton, D. V. (n.d.). A history of United States cannabis law. Journal of Law & Health, 34(1). https://engagedscholarship.csuohio.edu/cgi/viewcontent.cgi?article=1567&context=jlh

    Voir plus Voir moins
    1 h
  • Ep. 43 - Risky Buzzness - Driving While High (Part 2)

    Ep. 43 - Risky Buzzness - Driving While High (Part 2)
    Nov 13 2024
    Previous research has indicated that driving impaired while under the influence of cannabis can increase safety concerns for both driver and passengers, and that cannabis users are more likely to drive while impaired because of the perception that drugged driving is not as risky as drunk driving. However, prior driving research studies focused mainly on healthy individuals using intoxicating levels of THC, which do not provide real-world evidence of how new paradigms, such as medical cannabis, influence driving while high. In this episode of Cannabis Nurse Truths, we examine the safety concerns and current attitudes related to driving while high, and we emphasize an immediate need for more reliable drug testing methods and public education campaigns. EPISODE RESOURCES Boicu, B., Al-Hakim, D., Yuan, Y., & Brubacher R. J. (2024). Attitudes toward driving after cannabis use: A systematic review and meta-analysis. Transportation Research Part F: Traffic Psychology and Behaviour, 106, 418–430. https://doi.org/10.1016/j.trf.2024.08.005 Brooks-Russell, A., Brown, T., Rapp-Olsson, A. M., Friedman, K., & Kosnett, M. (2019). Driving after cannabis use and compensatory driving behaviors among current cannabis users in Colorado. Traffic Injury Prevention, 20(sup2), S199–S201. https://www.tandfonline.com/doi/full/10.1080/15389588.2019.1665424 Brown, T., Banz, B., Schmitt, R., Gaffney, G., Milavetz, G., Camenga, D., Li, K., Brooks-Russell, A., & Vaca, F. (2022). A study of self-reported personal cannabis use and state legal status and associations with engagement in and perceptions of cannabis-impaired driving. Traffic Injury Prevention, 23(sup1), S183–S186. https://www.tandfonline.com/doi/full/10.1080/15389588.2022.2124803 Colizzi, M., & Bhattacharyya, S. (2018). Cannabis use and the development of tolerance: A systematic review of human evidence. Neuroscience and Biobehavioral Reviews, 93, 1-25. https://pubmed.ncbi.nlm.nih.gov/30056176/ Cuttler, C., Sexton, M., & Mischley, L. K. (2018). Driving under the influence of cannabis: An examination of driving beliefs and practices of medical and recreational cannabis users across the United States. Cannabis, 1(2), Article 2. https://publications.sciences.ucf.edu/cannabis/index.php/Cannabis/article/view/cannabis.2018.02.001 Di Ciano, P., Rajji, T. K., Hong, L., Zhao, S., Byrne, P., Elzohairy, Y., Brubacher, J. R., McGrath, M., Brands, B., Chen, S., Wang, W., Hasan, O. S. M., Wickens, C. M., Kaduri, P., & Le Foll, B. (2024). Cannabis and driving in older adults. JAMA Network Open, 7(1), e2352233. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814053 Dutra, L. M., Gourdet, C., Farrelly, M. C., & Bradfield, B. (2023). Perceived safety, not perceived legality, mediates the relationship between cannabis legalization and drugged driving. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 50(6), 718–727. https://pubmed.ncbi.nlm.nih.gov/35822623/ Jones, C., Donnelly, N., Swift, W., & Weatherburn, D. (2006). Preventing cannabis users from driving under the influence of cannabis. Accident; Analysis and Prevention, 38(5), 854–861. https://pubmed.ncbi.nlm.nih.gov/16574046/ Kraemer, M., Madea, B., & Hess, C. (2019). Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use? Drug Testing and Analysis, 11(10), 1498–1506. https://pubmed.ncbi.nlm.nih.gov/31407526/ Manning, B., Arkell, T. R., Hayley, A. C., & Downey, L. A. (2024). A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance. Journal of Psychopharmacology, 38(3), 247–257. https://journals.sagepub.com/doi/10.1177/02698811241229524 McDonald, A. J., Hamilton, H. A., Wickens, C. M., Watson, T. M., Elton-Marshall, T., Wardell, J. D., Rueda, S., Roerecke, M., Stoduto, G., & Mann, R. E. (2021). Driving under the influence of cannabis risk perceptions and behaviour: A population-based study in Ontario, Canada. Preventive Medicine, 153, 106793. https://www.sciencedirect.com/science/article/pii/S0091743521003625 Miller, R., Brown, T., Schmitt, R., Gaffney, G., & Milavetz, G. (2024). Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive. Accident Analysis & Prevention, 195, 107376. https://www.sciencedirect.com/science/article/abs/pii/S0001457523004232?via%3Dihub National Center for Statistics and Analysis. (2022). Alcohol-Impaired Driving: 2020 Data (Traffic Safety Facts. DOT HS 813 294) https://www.nhtsa.gov/data National Survey on Drug Use and Health (NSDUH). Results from the 2021 National Survey on Drug Use and Health: Detailed Tables. 2022; https://www.samhsa.gov/data/sites/default/files/reports/rpt39441/NSDUHDetailedTabs2021/NSDUHDetailedTabs2021/NSDUHDetailedTabsTOC2021.htm#toc Ramaekers, J. G., Kauert, G., Theunissen, E. L., ...
    Voir plus Voir moins
    1 h
  • Ep. 42 - Risky Buzzness: Driving While High (Part 1)

    Ep. 42 - Risky Buzzness: Driving While High (Part 1)
    Nov 6 2024
    Previous research has indicated that driving impaired while under the influence of cannabis can increase safety concerns for both driver and passengers, and that cannabis users are more likely to drive while impaired because of the perception that drugged driving is not as risky as drunk driving. However, prior driving research studies focused mainly on healthy individuals using intoxicating levels of THC, which do not provide real-world evidence of how new paradigms, such as medical cannabis, influence driving while high. In this episode of Cannabis Nurse Truths, we examine the safety concerns and current attitudes related to driving while high, and we emphasize an immediate need for more reliable drug testing methods and public education campaigns. EPISODE RESOURCES Boicu, B., Al-Hakim, D., Yuan, Y., & Brubacher R.J. (2024). Attitudes toward driving after cannabis use: A systematic review and meta-analysis. Transportation Research Part F: Traffic Psychology and Behaviour, 106, 418–430. https://doi.org/10.1016/j.trf.2024.08.005 Brooks-Russell, A., Brown, T., Rapp-Olsson, A.M., Friedman, K., & Kosnett, M. (2019). Driving after cannabis use and compensatory driving behaviors among current cannabis users in Colorado. Traffic Injury Prevention, 20(sup2), S199–S201. https://www.tandfonline.com/doi/full/10.1080/15389588.2019.1665424 Brown, T., Banz, B., Schmitt, R., Gaffney, G., Milavetz, G., Camenga, D., Li, K., Brooks-Russell, A., & Vaca, F. (2022). A study of self-reported personal cannabis use and state legal status and associations with engagement in and perceptions of cannabis-impaired driving. Traffic Injury Prevention, 23(sup1), S183–S186. https://www.tandfonline.com/doi/full/10.1080/15389588.2022.2124803 Colizzi, M., & Bhattacharyya, S. (2018). Cannabis use and the development of tolerance: A systematic review of human evidence. Neuroscience and Biobehavioral Reviews, 93, 1-25. https://pubmed.ncbi.nlm.nih.gov/30056176/ Cuttler, C., Sexton, M., & Mischley, L.K. (2018). Driving under the influence of cannabis: An examination of driving beliefs and practices of medical and recreational cannabis users across the United States. Cannabis, 1(2), Article 2. https://publications.sciences.ucf.edu/cannabis/index.php/Cannabis/article/view/cannabis.2018.02.001 Di Ciano, P., Rajji, T.K., Hong, L., Zhao, S., Byrne, P., Elzohairy, Y., Brubacher, J.R., McGrath, M., Brands, B., Chen, S., Wang, W., Hasan, O.S.M., Wickens, C.M., Kaduri, P., & Le Foll, B. (2024). Cannabis and driving in older adults. JAMA Network Open, 7(1), e2352233. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814053 Dutra, L.M., Gourdet, C., Farrelly, M.C., & Bradfield, B. (2023). Perceived safety, not perceived legality, mediates the relationship between cannabis legalization and drugged driving. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 50(6), 718–727. https://pubmed.ncbi.nlm.nih.gov/35822623/ Jones, C., Donnelly, N., Swift, W., & Weatherburn, D. (2006). Preventing cannabis users from driving under the influence of cannabis. Accident; Analysis and Prevention, 38(5), 854–861. https://pubmed.ncbi.nlm.nih.gov/16574046/ Kraemer, M., Madea, B., & Hess, C. (2019). Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use? Drug Testing and Analysis, 11(10), 1498–1506. https://pubmed.ncbi.nlm.nih.gov/31407526/ Manning, B., Arkell, T.R., Hayley, A.C., & Downey, L.A. (2024). A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance. Journal of Psychopharmacology, 38(3), 247–257. https://journals.sagepub.com/doi/10.1177/02698811241229524 McDonald, A.J., Hamilton, H.A., Wickens, C.M., Watson, T.M., Elton-Marshall, T., Wardell, J.D., Rueda, S., Roerecke, M., Stoduto, G., & Mann, R.E. (2021). Driving under the influence of cannabis risk perceptions and behaviour: A population-based study in Ontario, Canada. Preventive Medicine, 153, 106793. https://www.sciencedirect.com/science/article/pii/S0091743521003625 Miller, R., Brown, T., Schmitt, R., Gaffney, G., & Milavetz, G. (2024). Predicting changes in driving performance in individuals who use cannabis following acute use based on self-reported readiness to drive. Accident Analysis & Prevention, 195, 107376. https://www.sciencedirect.com/science/article/abs/pii/S0001457523004232?via%3Dihub National Center for Statistics and Analysis. (2022). Alcohol-Impaired Driving: 2020 Data (Traffic Safety Facts. DOT HS 813 294). National Highway Traffic Safety Administration. Office of Behavioral Safety Research. Available at https://www.nhtsa.gov/data National Survey on Drug Use and Health (NSDUH). (2022). Results from the 2021 National Survey on Drug Use and Health: Detailed Tables. 2022. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt39441...
    Voir plus Voir moins
    58 min